Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

Daiichi Sankyo Co., Ltd.. (12/1/15). "Press Release: Daiichi Sankyo Announces Reorganization of Its Research & Development Structure". Tokyo.

Region Region Martinsried
  Country Germany
Organisations Organisation Daiichi Sankyo Co., Ltd. (TSE: 4568.JP)
  Group Daiichi Sankyo (Group)
  Organisation 2 U3 Pharma GmbH
  Today Daiichi Sankyo (Group)
  Group Daiichi Sankyo (Group)
Product Product antibody cancer drug
Persons Person Nakayama, Joji (Daiichi Sankyo 201512 CEO)
  Person 2 Ishida, Noriaki (Daiichi Sankyo 201512 VP Corp Communications Dept)
     


Daiichi Sankyo Company, Limited (Chuo-Ku, Tokyo; hereinafter, Daiichi Sankyo) today announced its decision to close its research subsidiary, U3 Pharma GmbH (Martinsried, Germany; hereinafter, U3).

Daiichi Sankyo intends to strengthen its global research and development capabilities by increasing efficiency and streamlining processes. Based on this objective, the global R&D capacities have been reviewed and the Company has decided to concentrate core research functions of Daiichi Sankyo Group in future.

U3, with about 40 employees and which is engaged in research and development work on antibody targeting for cancer treatments, will transfer its current research and development tasks to the Biologics Function in Tokyo.

Daiichi Sankyo will provide a more detailed update on the impact of this announcement on its FY2015 business results at a later date.


Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Daiichi Sankyo (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top